EARLY INITIATION OF VASOPRESSIN REDUCES ORGAN FAILURE AND MORTALITY IN SEPTIC SHOCK.

Rydz, Alexandria C; Elefritz, Jessica L; Conroy, Megan; Disney, Kathryn A; Miller, Christopher J; Porter, Kyle; Doepker, Bruce A

Rydz, Alexandria C; Elefritz, Jessica L; Conroy, Megan; Disney, Kathryn A; Miller, Christopher J; Porter, Kyle; Doepker, Bruce A.

Afiliación

Elefritz JL; Department of Pharmacy, Ohio State University Wexner Medical Center, Columbus, Ohio.
Conroy M; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, Ohio State University College of Medicine, Columbus, Ohio.
Disney KA; Department of Pharmacy, University of Utah Hospital, Salt Lake City, Utah.
Porter K; Center for Biostatistics, Department of Biomedical Informatics, Ohio State University College of Medicine, Columbus, Ohio.
Doepker BA; Department of Pharmacy, Ohio State University Wexner Medical Center, Columbus, Ohio.

Shock ; 58(4): 269-274, 2022 10 01.

Article en En | MEDLINE | ID: mdl-36018257

Asunto(s)

Choque Séptico; Humanos; Vasoconstrictores/uso terapéutico; Estudios Retrospectivos; Estudios de Cohortes; Insuficiencia Multiorgánica/tratamiento farmacológico; Insuficiencia Multiorgánica/complicaciones; Vasopresinas/uso terapéutico; Norepinefrina/uso terapéutico

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Choque Séptico Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Shock Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google